Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Front Pediatr ; 11: 1195691, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37484773

RESUMO

Introduction: Pediatric surgery is essential to a well-functioning health system. Unmet surgical needs contribute to 6.7% of pediatric deaths in Malawi. Understanding the current state of pediatric surgical care in Malawi is necessary to recognize gaps and opportunities in service delivery and to develop evidence-based national planning and solutions. Methods: This narrative mini review synthesized the literature on the state of pediatric surgery in Malawi through the pillars of the World Health Organization's Health System Building Blocks. A search of PubMed, Embase, and Scopus databases was executed to identify relevant studies and a thematic analysis was performed. Further, to ensure contextual accuracy, pediatric surgeons from Malawi were consulted and involved in this review. Results: Twenty-six papers were identified. In Malawi's central hospitals, there are six specialist pediatric surgeons for a pediatric population of more than 8 million. There is limited pediatric surgical capacity at the district hospitals. There is little to no written evidence of the national governing and finance structures in place for pediatric surgical services. Discussion: In countries like Malawi, where a significant portion of the population comprises children, it is crucial to recognize that pediatric services are currently inadequate and fall short of the required standards. It is crucial to prioritize the enhancement of services specifically designed for this age group. This review aims to shed light on the existing gaps within pediatric surgical services in Malawi, providing valuable insights that can inform the development of comprehensive national surgical planning strategies.

2.
Cureus ; 15(6): e40251, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-37440804

RESUMO

A parathyroid crisis is characterized by a severe elevation in calcium, usually above 14-15 mg/dl alongside acute signs and symptoms of hypercalcemia. It is a rare but potentially life-threatening complication of primary hyperparathyroidism (PHPT). Among all primary hyperparathyroidism cases, parathyroid carcinoma accounts for only less than 1%. Although the definitive management is surgical parathyroidectomy, the exact timing of surgery is not well-established. We describe a case of a patient with abrupt onset of severe hypercalcemia who was managed medically and discharged for elective parathyroidectomy. This was because her workup was suspicious for parathyroid carcinoma, and there was a need to pursue a positron emission tomography (PET)-computed tomography (CT) scan to evaluate for other malignancies before proceeding with parathyroidectomy. The patient experienced the resolution of her symptoms of acute encephalopathy and improvement in her calcium levels from 22.3 mg/dl (8.8-10.2 mg/dl) on admission to 9.1 mg/dl on day 13 of hospitalization and discharge. In this report, we review the literature on the timing of parathyroidectomy in patients with a parathyroid crisis and how this has evolved over time with the use of new hypocalcemic agents. We discuss that parathyroidectomy performed emergently within 72 hours vs after 72 hours has not shown any significant impact on long-term survival in patients with parathyroid crisis. Moreover, medical management is crucial while waiting for surgery.

3.
Respir Med ; 185: 106481, 2021.
Artigo em Inglês | MEDLINE | ID: mdl-34077874

RESUMO

Non-invasive respiratory support (NRS) outside of the ICU has played an important role in the management of COVID-19 pneumonia. There is little data to guide selection of NRS modality. We present outcomes of NRS outside the ICU and discuss the effects of NRS on gas exchange with implications for management.


Assuntos
COVID-19/terapia , Unidades de Terapia Intensiva , Ventilação não Invasiva/métodos , Troca Gasosa Pulmonar/fisiologia , SARS-CoV-2 , Idoso , Idoso de 80 Anos ou mais , COVID-19/epidemiologia , COVID-19/fisiopatologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Resultado do Tratamento
4.
Asian Pac J Cancer Prev ; 21(4): 1025-1029, 2020 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-32334465

RESUMO

Breast cancer is a heterogeneous hormone-dependent disease. Potential prognosis depends on the clinicopathological evaluation and assessment of other prognostic indicators. The detection of the oestrogen Receptor (ER), Progesterone Receptor (PR), Human epidermal growth factor receptor 2 (Her2/neu) and BRCA1 oncoprotein is pivotal for prognostic evaluation and to choose the appropriate post-surgical adjuvant therapy beside selecting the proper candidate for genetic counselling. OBJECTIVES: To detect the immunoexpression of the BRCA1 oncoprotein in mammary invasive ducal carcinoma and its association with the prognostic markers (ER, PR and Her2/neu hormonal receptors) and other clinicopathological parameters to improve the patients' treatment plans. METHODS: A cross-sectional study design including 83 paraffin blocks and histological slides collected from Al-Jumhoori Medical City Teaching Hospital Laboratory in Mosul and the Central Public Health Laboratory in Baghdad between the 1st of January 2010 to the 13th of March 2012 for patients diagnosed with primary invasive ductal breast carcinomas. Immunohistochemistry (IHC) using monoclonal antibodies against ER, PR, Her2/neu receptors and BRCA1 protein was performed via the fully automated immunostaining instrument 'Ventana Benchmark'. RESULTS: BRCA1 protein immunoexpression was detected in 20.5% of cases. It was significantly high with increasing tumour grade and stage. Although there was a trend of BRCA1 negativity toward negative ER, PR and Her2 receptors, no significant associations were observed with any of these parameters and the patients' age. CONCLUSION: Altered BRCA1 expression is significantly associated with advanced tumour grade and stage. High number of cases with negative BRCA1 expression showed negative ER, PR and Her2/neu expression.


Assuntos
Proteína BRCA1/metabolismo , Neoplasias da Mama/patologia , Carcinoma Ductal de Mama/patologia , Imuno-Histoquímica/métodos , Receptor ErbB-2/metabolismo , Receptores de Estrogênio/metabolismo , Receptores de Progesterona/metabolismo , Adulto , Idoso , Biomarcadores Tumorais/metabolismo , Neoplasias da Mama/metabolismo , Carcinoma Ductal de Mama/metabolismo , Estudos Transversais , Feminino , Seguimentos , Humanos , Pessoa de Meia-Idade , Prognóstico , Adulto Jovem
6.
Neuron ; 88(5): 941-956, 2015 Dec 02.
Artigo em Inglês | MEDLINE | ID: mdl-26606998

RESUMO

NG2-expressing glia (NG2 glia) are a uniformly distributed and mitotically active pool of cells in the central nervous system (CNS). In addition to serving as progenitors of myelinating oligodendrocytes, NG2 glia might also fulfill physiological roles in CNS homeostasis, although the mechanistic nature of such roles remains unclear. Here, we report that ablation of NG2 glia in the prefrontal cortex (PFC) of the adult brain causes deficits in excitatory glutamatergic neurotransmission and astrocytic extracellular glutamate uptake and induces depressive-like behaviors in mice. We show in parallel that chronic social stress causes NG2 glia density to decrease in areas critical to Major Depressive Disorder (MDD) pathophysiology at the time of symptom emergence in stress-susceptible mice. Finally, we demonstrate that loss of NG2 glial secretion of fibroblast growth factor 2 (FGF2) suffices to induce the same behavioral deficits. Our findings outline a pathway and role for NG2 glia in CNS homeostasis and mood disorders.


Assuntos
Antígenos/metabolismo , Depressão/patologia , Fator 2 de Crescimento de Fibroblastos/metabolismo , Neuroglia/metabolismo , Córtex Pré-Frontal/patologia , Proteoglicanas/metabolismo , Estresse Psicológico/fisiopatologia , Sistema X-AG de Transporte de Aminoácidos/genética , Sistema X-AG de Transporte de Aminoácidos/metabolismo , Animais , Antígenos/genética , Depressão/etiologia , Toxina Diftérica/administração & dosagem , Modelos Animais de Doenças , Regulação para Baixo/genética , Comportamento Exploratório/fisiologia , Fator 2 de Crescimento de Fibroblastos/genética , Fator de Crescimento Semelhante a EGF de Ligação à Heparina/genética , Humanos , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/genética , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Fosfopiruvato Hidratase/metabolismo , Transporte Proteico/efeitos dos fármacos , Transporte Proteico/genética , Proteoglicanas/genética , Receptores de Glutamato/genética , Receptores de Glutamato/metabolismo , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Transmissão Sináptica/efeitos dos fármacos , Transmissão Sináptica/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...